Effect of Transjugular Intrahepatic Portosystemic Shunt on Gut Microbiota in Cirrhotic Patients

NCT02427906 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2015-10-27

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of transjugular intrahepatic portosystemic shunt on gut microbiota and associated inflammatory factors in cirrhotic patients.

Conditions

  • Cirrhosis
  • Acquired Portal-systemic Shunt Due to Cirrhosis
  • Hepatic Encephalopathy

Sponsors & Collaborators

  • West China Hospital

    lead OTHER

Principal Investigators

  • Zhu Wang, PhD · West China Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02427906 on ClinicalTrials.gov